The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $284.7 in the prior trading day, AMGEN Inc (NASDAQ: AMGN) closed at $288.23, up 1.24%. In other words, the price has increased by $1.24 from its previous closing price. On the day, 1.8 million shares were traded. AMGN stock price reached its highest trading level at $288.4925 during the session, while it also had its lowest trading level at $283.49.
Ratios:
Our goal is to gain a better understanding of AMGN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.63. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 7.57 whereas as Long-Term Debt/Eq ratio is at 7.24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 05 ’25 when Khosla Rachna sold 1,500 shares for $289.68 per share. The transaction valued at 434,520 led to the insider holds 8,162 shares of the business.
Khosla Rachna bought 1,500 shares of AMGN for $435,000 on Jun 05 ’25. On May 02 ’25, another insider, Busch Matthew C., who serves as the VP, Finance & CAO of the company, sold 1,000 shares for $279.69 each. As a result, the insider received 279,690 and left with 4,034 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMGN now has a Market Capitalization of 155172077568 and an Enterprise Value of 203348033536. As of this moment, AMGEN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.58, and their Forward P/E ratio for the next fiscal year is 13.36. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.46 while its Price-to-Book (P/B) ratio in mrq is 20.89. Its current Enterprise Value per Revenue stands at 5.824 whereas that against EBITDA is 12.667.
Stock Price History:
The Beta on a monthly basis for AMGN is 0.48, which has changed by -0.09928125 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, AMGN has reached a high of $339.17, while it has fallen to a 52-week low of $253.30. The 50-Day Moving Average of the stock is -1.60%, while the 200-Day Moving Average is calculated to be -0.79%.
Shares Statistics:
The stock has traded on average 2.56M shares per day over the past 3-months and 2351690 shares per day over the last 10 days, according to various share statistics. A total of 538.30M shares are outstanding, with a floating share count of 537.25M. Insiders hold about 0.21% of the company’s shares, while institutions hold 81.24% stake in the company. Shares short for AMGN as of 1752537600 were 14702181 with a Short Ratio of 5.73, compared to 1749772800 on 13271690. Therefore, it implies a Short% of Shares Outstanding of 14702181 and a Short% of Float of 2.74.
Dividends & Splits
In the trailing 12 months, AMGN’s forward annual dividend rate was 9.26, compared to 9.26 this year. Against a Trailing Annual Dividend Yield of 0.032525465The stock’s 5-year Average Dividend Yield is 3.03. The current Payout Ratio is 119.05% for AMGN, which recently paid a dividend on 2025-05-16 with an ex-dividend date of 2025-08-22. Stock splits for the company last occurred on 1999-11-22 when the company split stock in a 2:1 ratio.
Earnings Estimates
The market rating for AMGEN Inc (AMGN) is a result of the insights provided by 23.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $5.19, with high estimates of $5.74 and low estimates of $4.83.
Analysts are recommending an EPS of between $21.62 and $20.58 for the fiscal current year, implying an average EPS of $21.04. EPS for the following year is $21.56, with 30.0 analysts recommending between $23.2 and $20.06.
Revenue Estimates
21 analysts predict $9B in revenue for the current quarter. It ranges from a high estimate of $9.2B to a low estimate of $8.78B. As of the current estimate, AMGEN Inc’s year-ago sales were $8.5BFor the next quarter, 21 analysts are estimating revenue of $9.35B. There is a high estimate of $9.66B for the next quarter, whereas the lowest estimate is $9.08B.
A total of 28 analysts have provided revenue estimates for AMGN’s current fiscal year. The highest revenue estimate was $36.18B, while the lowest revenue estimate was $35.09B, resulting in an average revenue estimate of $35.65B. In the same quarter a year ago, actual revenue was $33.42BBased on 29 analysts’ estimates, the company’s revenue will be $36.23B in the next fiscal year. The high estimate is $37.92B and the low estimate is $34.74B.
